Literature DB >> 29509279

Abnormal development of the inferior temporal region in fetuses with Down syndrome.

Sandra Guidi1, Andrea Giacomini1, Fiorenza Stagni1, Marco Emili1, Beatrice Uguagliati1, Maria Paola Bonasoni2, Renata Bartesaghi1.   

Abstract

Down syndrome (DS) is a genetic condition associated with impairment in several cognitive domains. Previous evidence showed a notable neurogenesis reduction in the hippocampal region of DS fetuses, which may account for the impairment of declarative memory that characterizes DS starting from early life stages. The fusiform gyrus (FG) and the inferior temporal gyrus (ITG) play a key role in visual recognition memory, a function that is impaired in children and adults with DS. The goal of the current study was to establish whether fetuses with DS (17-21 weeks of gestation) exhibit neuroanatomical alterations in the FG and ITG that may underlie recognition memory impairment. We found that the FG and ITG of fetuses with DS had a reduced thickness and fewer cells in comparison with euploid fetuses. Moreover, DS fetuses had fewer cells expressing the neuronal marker NeuN than euploid fetuses, but a similar number of cells expressing the astrocytic marker GFAP and, consequently, a higher percentage of astrocytes. Immunohistochemistry for calretinin (CR), a marker of GABAergic interneurons, showed that in DS fetuses the ratio of CR-positive vs. CR-negative cells was greater than in euploid fetuses, both in the FG (177%) and ITG (161%). An increased ratio of CR-positive vs. CR-negative cells was also found in the entorhinal cortex, hippocampus and dentate gyrus. Results provide novel evidence that the FG and ITG of DS fetuses exhibit numerous developmental defects. These defects may underlie the functional alterations in visual recognition memory observed in children with DS.
© 2018 International Society of Neuropathology.

Entities:  

Keywords:  Down syndrome; calretinin; cellularity; fetal brain; neurogenesis; temporal lobe

Mesh:

Substances:

Year:  2018        PMID: 29509279     DOI: 10.1111/bpa.12605

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  16 in total

1.  Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.

Authors:  Tomo Tarui; Kiho Im; Neel Madan; Rajeevi Madankumar; Brian G Skotko; Allie Schwartz; Christianne Sharr; Steven J Ralston; Rie Kitano; Shizuko Akiyama; Hyuk Jin Yun; Ellen Grant; Diana W Bianchi
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

2.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

Review 3.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

4.  Altered patterning of trisomy 21 interneuron progenitors.

Authors:  Yathindar Giffin-Rao; Jie Sheng; Bennett Strand; Ke Xu; Leslie Huang; Margaret Medo; Kirstin A Risgaard; Samuel Dantinne; Sruti Mohan; Aratrika Keshan; Roger A Daley; Bradley Levesque; Lindsey Amundson; Rebecca Reese; André M M Sousa; Yunlong Tao; Daifeng Wang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Stem Cell Reports       Date:  2022-05-26       Impact factor: 7.294

5.  Regional Alterations in Cortical Sulcal Depth in Living Fetuses with Down Syndrome.

Authors:  Hyuk Jin Yun; Juan David Ruiz Perez; Patricia Sosa; J Alejandro Valdés; Neel Madan; Rie Kitano; Shizuko Akiyama; Brian G Skotko; Henry A Feldman; Diana W Bianchi; P Ellen Grant; Tomo Tarui; Kiho Im
Journal:  Cereb Cortex       Date:  2021-01-05       Impact factor: 5.357

6.  The Acquisition of Survey Knowledge by Individuals With Down Syndrome.

Authors:  Zachary M Himmelberger; Edward C Merrill; Frances A Conners; Beverly Roskos; Yingying Yang; Trent Robinson
Journal:  Front Hum Neurosci       Date:  2020-07-03       Impact factor: 3.169

7.  Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models.

Authors:  Benoit Souchet; Arnaud Duchon; Yuchen Gu; Julien Dairou; Claire Chevalier; Fabrice Daubigney; Valérie Nalesso; Nicole Créau; Yuejin Yu; Nathalie Janel; Yann Herault; Jean Maurice Delabar
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

Review 8.  New approaches to studying early brain development in Down syndrome.

Authors:  Ana A Baburamani; Prachi A Patkee; Tomoki Arichi; Mary A Rutherford
Journal:  Dev Med Child Neurol       Date:  2019-05-17       Impact factor: 5.449

Review 9.  Genes Associated with Disturbed Cerebral Neurogenesis in the Embryonic Brain of Mouse Models of Down Syndrome.

Authors:  Keiichi Ishihara
Journal:  Genes (Basel)       Date:  2021-10-11       Impact factor: 4.096

10.  Assessment of radial glia in the frontal lobe of fetuses with Down syndrome.

Authors:  Ana A Baburamani; Regina T Vontell; Alena Uus; Maximilian Pietsch; Prachi A Patkee; Jo Wyatt-Ashmead; Evonne C Chin-Smith; Veena G Supramaniam; J Donald Tournier; Maria Deprez; Mary A Rutherford
Journal:  Acta Neuropathol Commun       Date:  2020-08-20       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.